Patents by Inventor Iris Chan

Iris Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPIES
    Publication number: 20240046303
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
    Type: Application
    Filed: August 17, 2023
    Publication date: February 8, 2024
    Inventors: Gordon Bray, Iris Chan
  • Combination therapies
    Patent number: 11783366
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: October 10, 2023
    Assignee: Genentech, Inc.
    Inventors: Gordon Bray, Iris Chan
  • COMBINATION THERAPIES
    Publication number: 20220172244
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
    Type: Application
    Filed: August 9, 2021
    Publication date: June 2, 2022
    Inventors: Gordon Bray, Iris Chan
  • Combination therapies
    Patent number: 11087354
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: August 10, 2021
    Assignee: Genentech, Inc.
    Inventors: Gordon Bray, Iris Chan
  • COMBINATION THERAPIES
    Publication number: 20140093568
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. More specifically, the invention relates to therapies for the treatment of pathological conditions, such as cancer.
    Type: Application
    Filed: August 15, 2013
    Publication date: April 3, 2014
    Applicant: Genentech, Inc.
    Inventors: Gordon Bray, Iris Chan